An interventional study of Art Intervention in Epilepsy and Migraine, sponsored by Dartmouth-Hitchcock Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-18.
Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Other
The purpose of the study is to assess the feasibility of a Creative Artists Program intervention with epilepsy and headache patients admitted to Dartmouth-Hitchcock Medical Center for care by the Department of Neurology.
Qualifying patients admitted to Epilepsy monitoring or Headache treatment will be approached for participation in the study. Patients who consent to the study will be given a chance to work with one of three creative artists (visual artist, creative writer, therapeutic musician). The artist will be selected according to a pre-determined schedule, and the arts intervention may last up to 90 minutes. Subjects will be asked to complete study questionnaires before and after the arts intervention.
1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.
This study's enrollment of 33 is below the median of 50 across 1,206 interventional studies indexed under Epilepsy.
Browse Epilepsy studies →Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.
Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
One of the three artists (visual artist, music therapist, creative writer) will work with subjects for up to 90 minutes.
Other: Art Intervention
Type of artist intervention will be determined by the subject and the assigned artist.
Feasibility of conducting a creative arts intervention study
The feasibility of the creative intervention will be determined by the completion rates of the initial intervention attempts. If less than 50% of patients complete the intervention it will be deemed unfeasible in the current format.
Time frame: Through study completion, approximately 1 year
Change in patient anxiety before and after the intervention
Change in anxiety level will be calculated, based on patient questionnaire responses, following the creative intervention.
Time frame: Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in patient distress before and after the intervention
Change in distress level will be calculated, based on patient questionnaire responses, following the creative intervention.
Time frame: Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in patient depression before and after the intervention
Change in depression level will be calculated, based on patient questionnaire responses, following the creative intervention.
Time frame: Each patient will be assessed at baseline (Day 1) and after the intervention (approximately Day 3 - 21).
Change in frequency of as-needed pain medication use
As-needed pain medication utilization will be evaluated following the creative arts intervention through subject discharge.
Time frame: Each patient as-needed medication use will be assessed after the arts intervention and until discharge from the hospital (approximately Day 3 - 21).
Length of hospital stay
Length of hospital stay will be calculated.
Time frame: Each patient's admission duration (approximately 3 - 21 Days).
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dartmouth-Hitchcock Medical Center